Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues

PrZen/33306615
CMP is an educational and accredited CME / CE live activity which, due to its multidisciplinary nature, will highlight the endocannabinoid system, its management, and relevant policy and laws. The faculty will speak from their expertise as physicians and lawyers in the marijuana industry. Participants will learn about medicinal cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education

DENVER - PrZen -- We are pleased to announce our inaugural CME / CE conference, Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP2019).

Connect with your colleagues from around the world, get fresh perspectives, deepen your understanding of the endocannabinoid system – and earn CME credit! This is the not-to-miss event of the year with expert speakers in the field.

We are excited to announce that registration is now open (our site is best viewed on Firefox, Chrome, Safari, or Edge).

Earn up to 7.5 CME/CE credits and 2 COPIC points in one location while taking in the latest evidence-based data that highlights the challenges you and your patients face daily.

This accredited CME / CE live activity is an educational and scientific event which, due to its multidisciplinary nature, will highlight the endocannabinoid system, its management, and relevant policies and laws. The faculty will speak from their expertise as physicians and lawyers in the marijuana industry

CMP 2019 is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medicinal cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support systems.

Regardless of your role in the medical community, this symposium is for you!

Learning Objectives
After completing this activity, participants should be able to:

  1. Outline the endocannabinoid system.
  2. Review the current evidence-based indications for the use of cannabis.
  3. Review the effects of cannabis use, including physiological effects.
  4. Describe the Colorado experience after mass commercialization of cannabis for medical purposes.
  5. Review Colorado Medical Board Rules, Regulations, and Policies impact on cannabinoid use.
  6. Recognize FDA policy and regulation of CBD-containing products for therapeutic use.
  7. Explain the interaction of cannabis and opioids.
  8. Review the known risks for psychiatric complications related to cannabinoid use.
  9. Discuss recent studies of cannabinoids in the treatment of psychiatric disorders.
  10. Discuss what is known about cannabinoid exposure in developing brains.
  11. Identify major epidemiological trends associated with cannabis legalization.
  12. Describe common emergency department presentations related to cannabis use.
  13. Identify best practices for discussing cannabinoid use in Colorado's legal and regulatory climate.
Target Audience:

This educational activity is designed to meet the needs of primary care practitioners inclusive of: physicians, nurse practitioners, physician assistants, and pharmacists who have interest in the emerging field of cannabis.

We look forward to seeing you at CMP2019! Register Today!

Contact
John - CMP Symposium
info@cmpsymposium.com
3033951782


Source: CMP Symposium, Global Education Group, COPIC
stats
Show All News | Report Violation

0 Comments
1000 characters max.

Latest on PrZen